H

    Hyperfine Inc (HYPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.82
    -0.01 (-1.07%)

    Market Cap: $88.36M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(14/18)
    Avg Surprise
    -2.95%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.08
    Range$-0.08 - $-0.08
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.09-12.5%
    60d ago$-0.09-12.5%
    30d ago$-0.09-12.5%
    7d ago$-0.09-12.5%
    Current$-0.08
    Revenue Consensus
    $5M
    Range$5M - $5M
    3 analysts
    Dec 31, 2026
    EPS Consensus$-0.08
    Range$-0.08 - $-0.08
    2 analysts
    Revenue Consensus
    $7M
    Range$7M - $8M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.08---
    Sep 26EST
    		-$-0.08---
    Jun 26
    		$-0.09$-0.09+0.00%Beat+25.0%
    Mar 26
    		$-0.09$-0.11+19.73%Beat+26.4%
    Dec 25
    		$-0.08$-0.08+0.00%Beat+42.9%
    Sep 25
    		$-0.14$-0.10-40.00%Miss+0.0%
    Jun 25
    		$-0.12$-0.12+0.00%Beat+14.3%
    Mar 25
    		$-0.12$-0.12+0.00%Beat+14.3%
    Dec 24
    		$-0.14$-0.14+0.00%Beat+6.7%
    Sep 24
    		$-0.14$-0.14+0.00%Beat+6.7%
    Jun 24
    		$-0.14$-0.14+0.00%Beat+6.7%
    Mar 24
    		$-0.14$-0.15+6.67%Beat+17.6%
    Dec 23
    		$-0.15$-0.18+16.67%Beat+21.1%
    Sep 23
    		$-0.15$-0.16+6.25%Beat+21.1%
    Jun 23
    		$-0.15$-0.16+6.25%Beat+54.5%
    Mar 23
    		$-0.17$-0.13-30.77%Miss+50.0%
    Dec 22
    		$-0.19$-0.25+24.00%Beat+48.6%
    Sep 22
    		$-0.19$-0.26+26.92%Beat-533.3%
    Jun 22
    		$-0.33$-0.26-26.92%Miss-560.0%
    Mar 22
    		$-0.34$-0.21-61.90%Miss-3300.0%
    Dec 21
    		$-0.37N/AN/ABeat-
    Sep 21
    		$-0.03N/AN/ABeat-
    Jun 21
    		$-0.05N/AN/ABeat-
    Mar 21
    		$-0.01N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-2.07EV/EBITDA-0.72x
    Price/FCF-2.99xFCF Yield-33.47%
    Profitability
    Profit Margin-210.70%Operating Margin-216.90%
    ROE-97.00%ROIC-55.60%
    Financial Health
    Debt/Equity0.36xInterest CoverageN/A
    Current Ratio6.15xQuick Ratio5.45x
    Trading Statistics
    Beta1.43Avg Volume562.53K
    52-Week High$2.2252-Week Low$0.83

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.87
    SMA 20$0.91
    SMA 50$1.05
    SMA 200$1.18
    EMA 10$0.86
    EMA 20$0.90
    EMA 50$1.03
    EMA 200$1.16

    MACD

    Line: -0.05Signal: -0.06Hist: 0.00

    ADX

    ADX: 24.5+DI: 9.1-DI: 20.4

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down100.0
    PSAR$0.96

    Bollinger Bands

    Upper Band$1.01
    Lower Band$0.80
    %B Position2343%(Upper)
    Band Width0.11

    RSI (14-Day)

    Oversold
    28.7

    Momentum Oscillators

    Stoch %K5.5
    Stoch %D8.7
    Williams %R-92.3
    ROC (10d)-8.0%
    Momentum-0.07
    CCI (20d)-131.3
    MFI (14d)26.5

    Volatility Measures

    ATR (14d)$0.06(6.8%)
    StdDev (20d)0.05
    Hist Vol38.7%(Moderate)

    Volume Flow

    VWAP$0.83
    OBV110.6M
    AD Line-24.4M
    CMF (20d)-0.260

    Volume Metrics

    Avg Vol (20d)570.5K
    Vol Ratio0.5x
    VWMA (20d)$0.91

    Pivot Points

    R3$0.88
    R2$0.87
    R1$0.85
    Pivot Point$0.84
    S1$0.82
    S2$0.81
    S3$0.80

    Advanced Oscillators

    TSI-34.18
    Ultimate Osc37.1
    KST-138.36

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.90M$3.90M$5.29M$3.44M$2.70M$2.14M$2.32M$3.64M$3.63M$3.29M$2.69M$2.33M
    Cost of Revenue$1.92M$1.92M$2.60M$1.59M$1.37M$1.25M$1.50M$1.74M$1.83M$1.94M$1.65M$1.21M
    Gross Profit$1.98M$1.98M$2.69M$1.85M$1.33M$883,000$826,000$1.91M$1.80M$1.35M$1.03M$1.12M
    Operating Expenses$10.45M$10.54M$10.36M$10.77M$10.92M$11.79M$11.59M$12.87M$12.65M$12.00M$12.66M$12.88M
    R&D$3.87M$3.85M$3.83M$4.05M$4.54M$5.04M$5.11M$5.87M$5.96M$5.57M$5.96M$5.74M
    SG&A$3.91M$4.13M$4.03M$4.15M$3.86M$4.21M$4.13M$4.51M$4.42M$4.43M$4.17M$4.62M
    Operating Income$-8,469,000$-8,558,000$-7,668,000$-8,920,000$-9,595,000$-10,902,000$-10,765,000$-10,963,000$-10,846,000$-10,650,000$-11,629,000$-11,759,000
    Interest Income$272,000$254,000$280,000$187,000$239,000$317,000$436,000$585,000$675,000$796,000$922,000$1.02M
    Interest Expense$533,000$83,000$0$2.10M$0$0$0$0$0$0$0$0
    Income Before Tax$-9,298,000$-8,623,000$-5,912,000$-11,019,000$-9,225,000$-9,418,000$-10,390,000$-10,326,000$-10,156,000$-9,848,000$-10,684,000$-10,757,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-9,298,000$-8,623,000$-5,912,000$-11,019,000$-9,225,000$-9,418,000$-10,390,000$-10,326,000$-10,156,000$-9,848,000$-10,684,000$-10,757,000
    EBITDA$-8,661,000$-8,503,000$-5,865,000$-10,909,000$-9,181,000$-9,506,000$-10,592,000$-10,652,000$-10,578,000$-10,381,000$-11,343,000$-11,500,000
    EBIT$-9,037,000$-8,794,000$-6,146,000$-11,206,000$-9,464,000$-9,735,000$-10,826,000$-10,911,000$-10,831,000$-10,644,000$-11,606,000$-11,778,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HYPR

    News

    HYPR | Hyperfine, Inc. Class A Financials - Revenue Breakdown

    This article provides a financial overview of Hyperfine, Inc. (HYPR), focusing on its revenue breakdown, government contracts, and other financial metrics. It details the company's business model, which involves selling MRI devices and providing related services for its Swoop Portable MR Imaging System, and notes the absence of detailed segment or geographic revenue data. The company has received several government contracts, primarily from the Department of Health and Human Services and the Department of Commerce.

    Quiver Quantitative•8/23/26•
    Neutral

    Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows

    Hyperfine (Nasdaq: HYPR) reported a 44.8% increase in Q2 2026 revenue, reaching $3.904 million, with commercial Swoop system sales rising and gross margin expanding, which helped narrow the operating loss. Despite operational improvements, the net loss remained nearly flat at $9.298 million due to interest expenses and a warrant-liability valuation loss. The company reaffirmed its full-year 2026 guidance, targeting substantial revenue growth and a moderate reduction in cash burn, while facing risks related to second-half execution, continued cash consumption, and financing dependence.

    TradingKey•8/6/26•
    Neutral

    Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M

    Hyperfine, Inc. reported a significant 44.8% increase in Q2 2026 revenue, reaching $3.9 million, with cash and cash equivalents growing to $43.5 million. The company also announced CE Mark and UKCA approvals and the European launch of its next-generation Swoop® portable MRI system, alongside record U.S. scan volumes. Despite these gains, Hyperfine remains loss-making, with a net loss of $9.3 million for the quarter and projected full-year 2026 cash burn of $26–$28 million.

    Stock Titan•8/6/26•
    Somewhat-Bullish

    OrthoPediatrics ( KIDS ) Reports Q2 Loss, Tops Revenue Estimates

    OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +16.13% and +3.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Commentary•8/4/26•
    Neutral

    Glaukos ( GKOS ) Reports Q2 Loss, Tops Revenue Estimates

    Glaukos (GKOS) delivered earnings and revenue surprises of +50.00% and +24.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Commentary•7/29/26•
    Neutral

    Frequently Asked Questions About HYPR

    Does HYPR pay dividends?
    Hyperfine Inc (HYPR) does not currently pay a regular dividend.
    What is HYPR's market cap?
    Hyperfine Inc (HYPR) has a market capitalization of $88.36M with a current stock price of $0.82.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In